[The effectiveness of paramunization for the control of feline coryza].
20 cats in a cat home were treated prophylactically and therapeutically with Baypamun HK. The animals were allocated into three groups as described. 7 freshly admitted clinically healthy cats were treated prophylactically on day 1, 2 and 9 with 1 ml Baypamun HK (group I). 7 cats, who already were allocated for one year in the home and were sick of the feline respiratory disease complex were treated as described for group I (group II). 6 further cats, who also showed symptoms of the feline respiratory disease complex and had stayed for one year in the home were treated with physiol.saline solution according to group I (group III). From all cats blood samples were taken at day 1, 3, 10 and 17. The blood samples were checked for antibodies against feline calicivirus (FCV), feline herpesvirus (FHV), panleukopenia virus (PLV), feline peritonitis virus (FIPV) and feline immunodeficiency virus (FIV). Also the occurrence of the feline leukemia virus (FeLV) was evaluated. The cellular immunity was evaluated by means of the lymphocyte transformations test (LTT), nitroblue-tetrazolium reduction test (NBT) and cytochrome C-reduction test (CRT). Mean value and standard deviation was calculated from the results. The significance was determined by the t-test. The animals were examined clinically daily for 20 days for the feline respiratory disease complex. When necessary, the animals were treated by homeopathic and antibiotic products. At the time of admission to the home all cats were or had been treated with an attenuated panleukopenia vaccine. The serologic parameters were not influenced in the cats of group I.(ABSTRACT TRUNCATED AT 250 WORDS)
Klimentowski
S
S
Bundesanstalt für Virusseuchenbekämpfung, Haustieren Wien-Hetzendorf.
Kölbl
S
S
Fischer
M
M
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D002371:Cat Diseases / Q000517:prevention & control*; D002415:Cats; D007111:Immunity, Cellular; D012141:Respiratory Tract Infections / Q000517:prevention & control / Q000662:veterinary*; D014765:Viral Vaccines; D014777:Virus Diseases / Q000517:prevention & control / Q000662:veterinary*
D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; C076692:Baypamun HK; D014765:Viral Vaccines
Untersuchungen über die Wirksamkeit der Paramunisierung zur Bekämpfung des Katzenschnupfens.